Anonymous: Change in solubility of insulin in therapeutic mixtures of insulin preparations: HPLC analysis. Diabetes News Digest1990 Mar:3.
2.
Galloway JA, et al. Clinical pharmacologic studies with human insulin (recombinant DNA). Diabetes Care1982;5(suppl 2):13-21.
3.
Olsson PO, Arnqvist H., Von Schenck H.Miscibility of human semisynthetic regular and Lente insulin and human biosynthetic regular and NPH insulin. Diabetes Care1987 ; 10:473-77.
4.
Velussi M., Cergnigoi A., Puglisi C., et al. Experimental study of the different potencies of biosynthetic and semisynthetic human insulin mixtures in the treatment of insulin-dependent diabetics. Curr Ther Res1989;46:390-97.
5.
Klauser R., Schernthaner G., Prager R.Mixtures of human intermediate and human regular insulin in type 1 diabetic patients. Diabetes Res Clin Pract1988;5:185-90.
6.
Berger M.Pharmacokinetics of subcutaneously injected insulin: the miscibility of short-and long-acting insulin preparations. In: Crepaldi G, et al, eds. Diabetes, obesity and hyperlipidemias . New York: Elsevier Science Publishers , 1985:427-31.
7.
Galloway JA, et al. Mixtures of intermediate-acting insulin (NPH and Lente) with regular insulin: an update. In: Skyler JS , ed. Insulin update: 1982. Princeton, NJ: Excerpta Medica, 1982: 111-19.
8.
Nolte MS, et al. Reduced solubility of short-acting soluble insulins when mixed with longer-acting insulins. Diabetes1983 ;32:1177-81.
9.
Binder C., et al. Insulin pharmacokinetics. Diabetes Care1984;7:188-99.
10.
Lauritzen T. , et al. Absorption of isophane (NPH) insulin and its clinical implications. Br Med J1982 ;285:159.
11.
Galloway JA , et al. Factors influencing the absorption serum insulin concentration, and blood glucose responses after injections of regular insulin and various insulin mixtures. Diabetes Care1981;3:366-76.
12.
Galloway JAChemistry and the clinical use of insulin. In: Galloway JA, Potvin JH, Shuman CR, eds. Diabetes mellitus, 9th ed. Indianapolis: Eli Lilly and Company, 1990:ch7.
13.
Jawadi MH, Ho LSStability and reproducibility of the biological activity of premixed short-acting and intermediate-acting insulins. Am J Med1986;81:467-71.
14.
Peters AL, Davidson MBEffect of storage on action of NPH and regular insulin mixtures. Diabetes Care1987;10:799-800.
15.
Kasmer RJ, Walker N., Hurlburt F., et al. Sterility of preloaded insulin syringes. Am J Infect Control1986; 14(4): 180-83.